184 related articles for article (PubMed ID: 30806106)
1. Myeloid neoplasm with eosinophilia and
Salehi S; Astle JM; Sadigh S; Lake J; Aikawa V; Tang G; Wang SA; Bagg A
Leuk Lymphoma; 2019 Sep; 60(9):2299-2303. PubMed ID: 30806106
[No Abstract] [Full Text] [Related]
2. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C
Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675
[TBL] [Abstract][Full Text] [Related]
3. PML-RARA fusion resulting from a cryptic insertion of RARA gene into PML gene without the reciprocal RARA-PML fusion: clinical, cytogenetic, and molecular characterization and prognosis.
Fan H; Ortega V; Fanasch HM; Wang Y; Holder KN; Higgins RA; Mendiola C; Mohamed G; Vadlamudi K; Velagaleti G
Eur J Haematol; 2014 Oct; 93(4):354-8. PubMed ID: 24673420
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Novel CSNK2A1-PDGFRB Fusion Gene in a Patient with Myeloid Neoplasm with Eosinophilia.
Xu X; Lu Q; Wang Z; Cai P; Zeng Z; Zhang L; Wang M; Ma L; Ruan C; Chen S
Cancer Res Treat; 2021 Jul; 53(3):889-892. PubMed ID: 33421986
[TBL] [Abstract][Full Text] [Related]
5. Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation.
Pardanani A; Lasho T; Barraco D; Patnaik M; Elala Y; Tefferi A
Am J Hematol; 2016 Mar; 91(3):E10-1. PubMed ID: 26663400
[No Abstract] [Full Text] [Related]
6. Blood and Bone Marrow Evaluation for Eosinophilia.
Boyer DF
Arch Pathol Lab Med; 2016 Oct; 140(10):1060-7. PubMed ID: 27684977
[TBL] [Abstract][Full Text] [Related]
7. Myeloid neoplasms with eosinophilia.
Reiter A; Gotlib J
Blood; 2017 Feb; 129(6):704-714. PubMed ID: 28028030
[TBL] [Abstract][Full Text] [Related]
8. Myeloproliferative neoplasm with eosinophilia and T-lymphoblastic lymphoma with ETV6-LYN gene fusion.
Telford N; Alexander S; McGinn OJ; Williams M; Wood KM; Bloor A; Saha V
Blood Cancer J; 2016 Apr; 6(4):e412. PubMed ID: 27058227
[No Abstract] [Full Text] [Related]
9. Sensitive monitoring of acute promyelocytic leukemia by PML-RARA DNA Q-PCR.
Kommers IO; Bartley PA; Budgen B; Latham S; Beligaswatte A; Supple SG; Catalano A; Iland HJ; Morley AA; Ross DM
Leuk Lymphoma; 2017 Jul; 58(7):1767-1769. PubMed ID: 27899039
[No Abstract] [Full Text] [Related]
10. [Myeloproliferative hypereosinophilic syndrome revealed by bipolar mucosal ulcerations].
Isvy-Joubert A; Hickman G; Flageul B; Battistella M; Bagot M; Galicier L; Petit A
Ann Dermatol Venereol; 2012 Oct; 139(10):636-40. PubMed ID: 23122377
[TBL] [Abstract][Full Text] [Related]
11. Atypical Phenotype and Treatment Response Pattern in a Patient with FIP1L1-PDGFRα Mutation.
Bikhchandani M; Johnson R; Tuan B; Tefferi A
Acta Haematol; 2018; 140(2):67-70. PubMed ID: 30184522
[TBL] [Abstract][Full Text] [Related]
12. Therapy-related myeloproliferative neoplasm with ETV6-PDGFRB rearrangement following treatment of acute promyelocytic leukemia.
Malfuson JV; Konopacki J; Fagot T; Desangles F; Bories D; Souleau B; de Revel T
Ann Hematol; 2011 Dec; 90(12):1477-9. PubMed ID: 21350831
[No Abstract] [Full Text] [Related]
13. Unusual presentation of myeloid sarcoma in a case of acute promyelocytic leukemia with a cryptic PML-RARA rearrangement involving multiple sites including the atrium.
Tirado CA; Chen W; Valdez F; Karandikar N; Arbini A; Acevedo I; Garcia R; Davila O; Smart RL; Matthews E; Kirk A; Collins RH
Cancer Genet Cytogenet; 2010 Jul; 200(1):47-53. PubMed ID: 20513534
[TBL] [Abstract][Full Text] [Related]
14. Drug sensitivity profiling identifies potential therapies for myeloid neoplasm with eosinophilia driven by a novel G3BP1-PDGFRB fusion gene.
Wang J; Xu L; Li Y; Wang J; Shao Y; Lai W; Yong J; Zhao L; Wei X; Gao C; Liu D; Gao X; Zhang Y
Leuk Lymphoma; 2024 Apr; 65(4):521-525. PubMed ID: 38157478
[No Abstract] [Full Text] [Related]
15. Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement.
Shao H; Wang W; Song J; Tang G; Zhang X; Tang Z; Srivastava J; Shah B; Medeiros LJ; Zhang L
Leuk Res; 2020 Dec; 99():106460. PubMed ID: 33166908
[TBL] [Abstract][Full Text] [Related]
16. Derivative (7)t(7;8): The sole karyotype abnormality in acute promyelocytic leukemia with PML/RARA rearrangement identified by RT-PCR and sequence analysis.
Wang Y; Fang M; Jing Y; Li J; Jiang F; Wang Y
Leuk Res; 2009 Jul; 33(7):e55-8. PubMed ID: 19162322
[No Abstract] [Full Text] [Related]
17. Identification of PML/RARalpha rearrangements in suspected acute promyelocytic leukemia using fluorescence in situ hybridization of bone marrow smears: a comparison with cytogenetics and RT-PCR in MRC ATRA trial patients. MRC Adult Leukaemia Working Party.
Iqbal S; Grimwade D; Chase A; Goldstone A; Burnett A; Goldman JM; Swirsky D
Leukemia; 2000 May; 14(5):950-3. PubMed ID: 10803535
[No Abstract] [Full Text] [Related]
18. Molecular analysis of the t(15;17) translocation in acute promyelocytic leukaemia.
Borrow J; Solomon E
Baillieres Clin Haematol; 1992 Oct; 5(4):833-56. PubMed ID: 1339190
[TBL] [Abstract][Full Text] [Related]
19. Acute promyelocytic leukemia in early pregnancy with translocation t(15;17) and variant PML/RARA fusion transcripts.
Park TS; Lee ST; Kim JS; Song J; Lee KA; Kim SJ; Seok YM; Lee HJ; Han JH; Kim JK; Lee EY; Choi JR
Cancer Genet Cytogenet; 2009 Jan; 188(1):48-51. PubMed ID: 19061780
[TBL] [Abstract][Full Text] [Related]
20. Myeloid neoplasm with eosinophilia and
Cook JR; Rogers HJ; Chandra PK; Prescott JL; Mukherjee S
Leuk Lymphoma; 2020 Jan; 61(1):213-216. PubMed ID: 31482743
[No Abstract] [Full Text] [Related]
[Next] [New Search]
